Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentnuclear speck

TCERG1 SON SETD1B

9.38e-04431103GO:0016607
GeneOntologyCellularComponentnuclear body

TCERG1 SON SETD1B

7.67e-03903103GO:0016604
Pubmed

Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.

TCERG1 FMNL3

6.76e-06141028605874
Pubmed

FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.

REST SETD1B

1.41e-052010227773593
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

POLR1G TCERG1 REST SON NAIF1

1.52e-05129410530804502
Pubmed

Aurora kinase A regulates Survivin stability through targeting FBXL7 in gastric cancer drug resistance and prognosis.

TCERG1 REST

5.20e-053810228218735
Pubmed

Human CIA2A-FAM96A and CIA2B-FAM96B integrate iron homeostasis and maturation of different subsets of cytosolic-nuclear iron-sulfur proteins.

FMNL3 SON

2.88e-048910223891004
CoexpressionGSE16266_CTRL_VS_LPS_STIM_MEF_UP

FMNL3 SH3TC1 REST

4.90e-05198103M7219
ToppCellcontrol-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

POLR1G NAIF1

4.63e-0414610269e9c1ec6eec1151290227902e75e77a4aecc8db
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells)

FMNL3 SH3TC1

4.82e-0414910241f28138bde45d0b814e116837e5a32b5e80d54a
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SH3TC1 OTOF

5.41e-041581021635a85fc73c544028418087f36d28957dd4f458
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SH3TC1 OTOF

5.41e-0415810280841dadfa53bcde36a3e486408a095f78e772eb
ToppCellPND10-Immune-Immune_Myeloid-DC-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

POLR1G OTOF

5.48e-041591027bb76324d2026d4bd348126cb169c8411f0d7145
ToppCellPND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

POLR1G OTOF

5.48e-04159102807ee55fe0d3645fbfb98f641dd0a0555b847cf5
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

TCERG1 OTOF

5.69e-04162102af9999e5fcd28ff1f401d52fd220315752c40027
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9

POLR1G TCERG1

5.97e-0416610252293b8a74d46e6161fb6a2e7e86e51fd9e89a5b
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9

SON SETD1B

5.97e-0416610232d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

OTOF SETD1B

6.12e-0416810250991eb794742592a0c96cd9a72460ab339e74ff
ToppCelldroplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FMNL3 SH3TC1

6.48e-041731029a04271c51fae34f547db3206f9ff5857686e45c
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

FMNL3 SH3TC1

7.48e-0418610274c238759c5d3fd39127ec0060d0c2cb16b326d4
ToppCellproximal-Hematologic-Myeloid_Dendritic_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

FMNL3 SETD1B

7.48e-04186102d740aca5dc4240851ba7bc5988c0970d785ad0c2
ToppCellproximal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

FMNL3 SETD1B

7.48e-04186102c920dffd24f051b54d8b48f801fffc928d99e135
ToppCellproximal-Hematologic-Myeloid_Dendritic_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

FMNL3 SETD1B

7.48e-041861024ca7f6c043874a0c536f75af5ca24c7c66725e54
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

FMNL3 SH3TC1

7.56e-04187102816d37a70f7ec382a268fe828b3dfe737a36a4bf
ToppCellTCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9

FMNL3 SH3TC1

7.65e-04188102c90669b51e1902fe7726555290c91c92a911df83
ToppCellH1299-infected|H1299 / Cell line, Condition and Strain

POLR1G SON

7.97e-041921029cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCellcontrol-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

REST SON

8.05e-0419310289d407a88b5956559a589425b89b3eb8dc78e1dd
ToppCellPBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters

OTOF SON

8.22e-04195102674355ca00314bde90ef7f6ddb83afe2d5323130
ToppCellBronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FMNL3 SH3TC1

8.30e-04196102b15812354128c12a588d79ef449d787e74835f3b
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FMNL3 SH3TC1

8.39e-04197102b597c292fc1cb381a4325fed15a32966c38def28
ToppCellSepsis-Int-URO-Others-RBC|Int-URO / Disease, condition lineage and cell class

POLR1G FMNL3

8.47e-0419810229203aaa5c1844f72289e03f585cd5e7fc498a9a
ToppCellSepsis-Int-URO-Others|Int-URO / Disease, condition lineage and cell class

POLR1G FMNL3

8.47e-0419810267f721ea8e60042317ba12efd584f56b07cfb29d
ToppCellTracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FMNL3 SH3TC1

8.56e-04199102744b63fba33b176ab7dde11646ccb313665505f7
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FMNL3 SH3TC1

8.56e-04199102e7faf7d0cb43cf93149c446e5f718f84fa85477c
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FMNL3 SH3TC1

8.56e-04199102b0a906586e58009f5ed9272fc29ba28e49c85ee6
ToppCellTracheal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FMNL3 SH3TC1

8.64e-04200102ad7ae5106141669b353800fece833b3cd5bdccee
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FMNL3 SH3TC1

8.64e-0420010280e0483d5ab0c6213aae0ec62619f57e6ec0e4c2
ToppCellTracheal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FMNL3 SH3TC1

8.64e-04200102f3dc07a7cc8cf041da8fe610d21af595818cf2d8
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type.

FMNL3 SH3TC1

8.64e-042001025c638c80661017c85f9390f1b398ac7728c8f001
DiseaseNonsyndromic genetic hearing loss

OTOF REST

2.91e-0476102cv:C5680182
DiseaseHereditary hearing loss and deafness

OTOF REST

1.07e-03146102cv:C0236038
Diseaseabdominal fat cell number

TCERG1 FMNL3

1.95e-03198102EFO_0021534
Diseaseperiodontitis

FMNL3 OTOF

2.46e-03223102EFO_0000649
Diseaseaspartate aminotransferase measurement

POLR1G SH3TC1 NAIF1

2.93e-03904103EFO_0004736
Diseasemyeloid white cell count

REST SETD1B NAIF1

3.24e-03937103EFO_0007988
Diseasepsoriasis

POLR1G SON

3.65e-03273102EFO_0000676
Diseasemigraine disorder

TCERG1 REST

6.16e-03357102MONDO_0005277

Protein segments in the cluster

PeptideGeneStartEntry
VQKGPVQVEPPPPME

REST

621

Q13127
EAPPPLPPETPVDMM

NAIF1

191

Q69YI7
LPPGKMPMPEPCELE

FMNL3

21

Q8IVF7
MEPTEPMEPTEPMEP

FADS6

1

Q8N9I5
PMEPTEPMEPTEPME

FADS6

6

Q8N9I5
PVDVDRGPIMPVPMG

OTOF

1111

Q9HC10
RMPETVPQEEMPGPP

POLR1G

471

O15446
PQDPIDDAMGGPVMP

SH3TC1

286

Q8TE82
DLEVEPEPPMMLPLP

SETD1B

1306

Q9UPS6
VMVPPFRVPLPGMPI

TCERG1

361

O14776
VLPGMAPPIVPMIHP

TCERG1

401

O14776
MGLEPPQEVPEPPVM

SON

461

P18583